Closing COVID-19 mortality, vaccination, and evidence gaps for those with severe mental illness, Lancet Psychiatry

In The Lancet Psychiatry, Dana Tzur Bitan and colleagues present the results of the first longitudinal study assessing COVID-19 outcomes before and after vaccination in a cohort of over 25 000 people with schizophrenia and an equally large sample of matched controls in Israel. Particular strengths of this study are the impressive and well-characterised dataset, and the longitudinal design, allowing exploration of dynamic trends over the course of the first year of the COVID-19 pandemic. From a policy perspective, Israel, where all citizens aged 16 and older gained full access to SARS-CoV-2 vaccination as early as January, 2021, represents an interesting case study.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news